Video

Spesolimab for Treatment of GPP

Experts discuss spesolimab, an IL-36 inhibitor, that was recently FDA approved for treatment of GPP.

Related Videos
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Importance of Birch Triterpene Findings for Epidermolysis Bullosa, with Anna Bruckner, MD
Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD
Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Crisis Point: Benzene Concerns in Acne Care
© 2025 MJH Life Sciences

All rights reserved.